NIOX Group plc
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:92 tCO2e/year
Scope 1 Emissions:0 tCO2e/year
Scope 2 Emissions:92 tCO2e/year
ESG Focus Areas
- Employee welfare
- Diversity and inclusion
- Health and safety
- Ethical conduct
- Environmental impact
Environmental Achievements
- Reduced scope 2 CO2 equivalent emissions from 59 tonnes in 2022 to 92 tonnes in 2023; implemented office-based initiatives to reduce waste (recycling of paper, cans, plastics, batteries, and printer toners/cartridges).
Social Achievements
- Implemented local focus groups for employee feedback; provided training on Code of Conduct and related policies, including diversity and equality; implemented annual development plans and flexible working policies; published a regular newsletter for staff; maintained a strong whistleblowing policy and established an Ethics and Compliance Hotline; promoted transparency of relationships with healthcare providers in compliance with the US Physician Payment Sunshine Act and equivalent legislation; supported UN Universal Declaration of Human Rights; encouraged charitable fundraising by employees.
Governance Achievements
- Maintained a strong ethical and values-driven culture; implemented policies on diversity and inclusion, the prevention of bribery and corruption, conflicts of interest, and anti-slavery; ensured full compliance with the UK Bribery Act 2010, the US Foreign Corrupt Practices Act, and other major anti-corruption legislation; carried out due diligence on new key business partners; implemented robust processes to ensure sales compliance requirements are met.
Climate Goals & Targets
Medium-term Goals:
- Introduce a product for use by patients to manage their condition at home.
Short-term Goals:
- Introduce FeNO testing in pharmacies and occupational health.
Environmental Challenges
- Increasing awareness and usage of FeNO testing in primary care; competition from companies with greater financial and human resources; ensuring payer coverage and inclusion of products by health insurance schemes; managing foreign exchange fluctuations; attracting, retaining, and developing employees.
Mitigation Strategies
- Engaging with respiratory professionals to promote the use of FeNO tests; investing in research and development to reduce costs and enhance products; implementing a market access strategy to ensure continued reimbursement; monitoring markets and making forward purchases of foreign currencies; implementing competitive compensation programs, long-term incentive plans, and robust internal communications; creating development opportunities for high-performing individuals.
Supply Chain Management
Responsible Procurement
- Long-term partnerships with third-party suppliers; dual sourcing investigated where practicable; close working with suppliers and contract manufacturers to identify and mitigate risks; due diligence on distributors and suppliers prior to contracting with them; audits of distributors and suppliers.
Climate-Related Risks & Opportunities
Sustainable Products & Innovation
- NIOX Pro® device
Awards & Recognition
- 2022 Research and Development Award
- 2023 Best Asthma Diagnosis and Management Company